display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
muscular invasive bladder cancer (MIBC)
MIBC - NA - all populationMIBC - NA - PDL1 positive
immune chekpoint inhibitors
anti-PD-(L)1
atezolizumab based treatment
atezolizumab alone IMvigor-010
nivolumab based treatment
nivolumab alone CheckMate 274 ... CheckMate 274 ...

Study type: